A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

NCT00179751 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: CC-5013
DRUG: gemcitabine

Sponsor

Celgene Corporation

Collaborators

[object Object]